Can Fite Biopharma
CANF
$2.14
Share price
3.38%
Change (1 day)
3.88%
Change (1 year)
Categories
EPS for Can Fite Biopharma (CANF)
EPS in 2023 (TTM): -$2.75
According to Can Fite Biopharma 's latest financial reports the company's current EPS (TTM) is -$2.75. In 2022 the company made an earnings per share (EPS) of -$3.00 an increase over its 2021 EPS that were of -$9.00.
EPS history for Can Fite Biopharma from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.75 | -8.21% |
| 2022 | -$3.00 | -66.67% |
| 2021 | -$9.00 | -33.38% |
| 2020 | -$13.51 | -64.07% |
| 2019 | -$37.60 | -26.27% |
| 2018 | -$51.00 | -10.53% |
| 2017 | -$57.00 | -36.67% |
| 2016 | -$90.00 | 44.58% |
| 2015 | -$62.25 | -40.15% |
| 2014 | -$104.01 | -47.45% |
| 2013 | -$197.92 | -77.14% |
| 2012 | -$865.88 | 127.17% |
| 2011 | -$381.15 |